Clinical Trial Update: Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating solifenacin (VESIcare) for symptom bother and health-related quality of life in adults with overactive bladder. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED | Results posted: 2010-10-05